Articles
|
February 19, 2009
|
On January 26, 2009, KV Pharmaceutical announced the voluntary recall of most of its products, in addition to the voluntary suspension of nearly all of its manufacture and shipping processes.
|
|
February 16, 2009
|
The California Supreme Court recently held that the mere exposure to an illegal term in a contract or unlawful practice, without some resulting damage, is insufficient to confer standing under the Consumers Legal Remedies Act ("CLRA") and that, without damage, declaratory relief is also properly denied.
|
|
February 16, 2009
|
The extent to which CDS have contributed to the unfolding financial maelstrom will be examined in the months and years to come. But for any party to a CDS, the immediate concern is knowing what rights and liabilities exist under their agreement.
|
|
February 2009
|
Los Angeles Lawyer
In the wake of the federal Class Action Fairness Act of 2005 (CAFA) and recent federal and state court decisions, no other type of settlement has drawn greater scrutiny by trial courts conducting class action fairness hearings than so-called coupon settlements. Yet what exactly constitutes a coupon settlement remains unsettled, particularly in the absence of a statutory definition in CAFA.
|
|
February 11, 2009
|
It is easy to overlook how foreign limitations on the attorney-client privilege can actually erode the privilege available in domestic courts.
|
|
February 4, 2009
|
On September 3, 2008, the FDA issued an Enforcement Report that included a Class II Recall of the BioSense Webster LASSO 2515 Variable Circular Mapping Catheter.
|
|
February 3, 2009
|
APaTS
...It's who says it -- at least when it comes to patent attorneys offering expert testimony in an infringement case.
|
|
January 30, 2009
|
The drug Chantix, sold by Pfizer to patients trying to quit smoking, has been associated with serious psychiatric side effects and even suicide.
|
|
January 26, 2009
|
The accelerated securitization of mortgage-backed securities (“MBS”) and other mortgage-related assets has created some of the most significant problems of the ongoing economic crisis. When investment banks and other financial institutions pooled numerous different assets, including highly risky sub-prime and Alt-A mortgages, and used them as collateral to create new, securitized financial assets, these assets eventually devalued to such a degree that they became so-called “toxic assets.”
|
|
January 21, 2009
|
BuLITS: Business Litigation Trial Strategies
Rivera v. Lutheran Med. Ctr., 866 N.Y.S.2d 520 (N.Y. Sup. Ct. 2008).
|